Stephen P.

Koios is a leading bespoke business software provider based in Newcastle Upon Tyne and London. The only Google Cloud Platform technology partner in the North East of England, we deliver cloud and on-premise business software solutions that deliver measurable client value through the intelligent application of technology. Our engineers operate primarily in the .Net and LAMP stacks but we retain niche skills in C++, Python, Perl and ADA.

WE ARE OCUCON - SEE EVERYTHING KNOW EVERYTHING Ocucon is a visionary technology company with the aim of helping businesses have a one stop shop to “see everything and know everything." Founded in 2016, Ocucon specialises in the development and sale of disruptive technological solutions designed to mitigate risks for businesses. Cloud by Ocucon is the world’s first Video Surveillance as a Service (VSaaS) system, providing unlimited storage for unlimited cameras within the cloud to defend against fraudulent slips, trips and falls. Breaking new grounds in surveillance technology, Cloud by Ocucon delivers a powerful, cloud-based storage and retrieval platform, combining intelligent data analytics with the facility to store, analyse and retrieve unlimited amounts of video surveillance footage from within the Ocucon portal. Ocucon’s multi-award winning cloud-based storage solution provides organisations with the flexibility to store uncapped amounts of data for as long as is required and access surveillance footage from anywhere in the world, at any time. Pixelate by Ocucon is a simple and cost effective solution to the GDPR requirement to redact, or blur, all third parties present in CCTV surveillance footage. OCCUPi by Ocucon enables retailers to coordinate and control the flow of shoppers in and out of stores with ease whilst cutting labour costs and ensuring staff safety.  SpillDetect is an innovative new solution for spill detection that's designed to reduce trips, slips, and falls on business premises. Using Artificial Intelligence built upon existing CCTV networks, SpillDetect provides the ideal solution to reduce liability and mitigate the risk of trips and slips. Winner of the 2019 RILA R(Tech) Asset Protection Innovation Awards Winner of the 2019 Digital Innovation Award, FSB Winner of 2020 Retail Tech Innovation Hub Awards To learn more, visit: https://ocucon.com/

About Biosignatures The problem we solve 25 years ago, GPs had just 2 blood tests they could use to see if a patient had cancer. Today, despite billions of pounds spent on medical research, they still only have those 2 tests. Biosignatures has solved the problems in life science research that caused this issue. What we do Biosignatures discovers new blood tests. Over 10 years, the company has developed a patented machine learning software technology which, combined with the company’s powerful sample measurement system is a disruptive, dramatically cost-effective step forward in the discovery of new clinical diagnostic tests. Our first product The company’s first product is a blood test for prostate cancer discovered with the UK’s NHS. In its first independently blinded validation trial it performed 4 times better than current clinical practice. It also holds great promise for wider application as a screen for the disease. Our potential In 2019 we will be embarking on a major project to analyse thousands of biobank samples, looking to build novel diagnostic screening tests. Biosignatures’ calculations suggest that existing biobanks are large enough to enable the company’s technologies to reliably generate 20 valuable diagnostic screens. For example - over 4,000 patients in the UKBiobank had no prostate cancer diagnosis when sampled but went onto to be diagnosed with the disease later. The market opportunity It is safe to say that if we can deliver on this vision - as we believe we can - it will be transformative for healthcare delivery world-wide. This is especially true for markets where genetic differences in populations mean that tests developed specifically for other populations may not work well. Developing tests for these markets plays perfectly to the company’s capabilities. A team with a track record Biosignatures’ management team has a strong background in technology companies including having founded, built and sold Nonlinear Dynamics Ltd.

Honcho Markets Ltd is developing a revolutionary and disruptive entrant to the insurance technology market that will redefine how consumers purchase products.

Realsafe Technologies is a public safety technology company that develops, maintains, and licences its award-winning smartphone-based crash detection and emergency alerting software. Our life-saving technology protects millions of miles of journeys by customers travelling within the automotive and motorcycle markets. The company works with major brands around the world helping protect those who crash, and may require urgent emergency assistance.

OnBoard Pro is advanced pre-tenancy software which is revolutionising the rental property industry. Using state-of-the-art software, OnBoard Pro aims to create a simpler, faster and more transparent way of renting properties. OnBoard Pro is an intelligent, integrated, user-friendly platform which allows the full tenancy application to be completed at a viewing. The decision can be instant saving you time and money!

Koios is a leading bespoke business software provider based in Newcastle Upon Tyne and London. The only Google Cloud Platform technology partner in the North East of England, we deliver cloud and on-premise business software solutions that deliver measurable client value through the intelligent application of technology. Our engineers operate primarily in the .Net and LAMP stacks but we retain niche skills in C++, Python, Perl and ADA.

WE ARE OCUCON - SEE EVERYTHING KNOW EVERYTHING Ocucon is a visionary technology company with the aim of helping businesses have a one stop shop to “see everything and know everything." Founded in 2016, Ocucon specialises in the development and sale of disruptive technological solutions designed to mitigate risks for businesses. Cloud by Ocucon is the world’s first Video Surveillance as a Service (VSaaS) system, providing unlimited storage for unlimited cameras within the cloud to defend against fraudulent slips, trips and falls. Breaking new grounds in surveillance technology, Cloud by Ocucon delivers a powerful, cloud-based storage and retrieval platform, combining intelligent data analytics with the facility to store, analyse and retrieve unlimited amounts of video surveillance footage from within the Ocucon portal. Ocucon’s multi-award winning cloud-based storage solution provides organisations with the flexibility to store uncapped amounts of data for as long as is required and access surveillance footage from anywhere in the world, at any time. Pixelate by Ocucon is a simple and cost effective solution to the GDPR requirement to redact, or blur, all third parties present in CCTV surveillance footage. OCCUPi by Ocucon enables retailers to coordinate and control the flow of shoppers in and out of stores with ease whilst cutting labour costs and ensuring staff safety.  SpillDetect is an innovative new solution for spill detection that's designed to reduce trips, slips, and falls on business premises. Using Artificial Intelligence built upon existing CCTV networks, SpillDetect provides the ideal solution to reduce liability and mitigate the risk of trips and slips. Winner of the 2019 RILA R(Tech) Asset Protection Innovation Awards Winner of the 2019 Digital Innovation Award, FSB Winner of 2020 Retail Tech Innovation Hub Awards To learn more, visit: https://ocucon.com/

About Biosignatures The problem we solve 25 years ago, GPs had just 2 blood tests they could use to see if a patient had cancer. Today, despite billions of pounds spent on medical research, they still only have those 2 tests. Biosignatures has solved the problems in life science research that caused this issue. What we do Biosignatures discovers new blood tests. Over 10 years, the company has developed a patented machine learning software technology which, combined with the company’s powerful sample measurement system is a disruptive, dramatically cost-effective step forward in the discovery of new clinical diagnostic tests. Our first product The company’s first product is a blood test for prostate cancer discovered with the UK’s NHS. In its first independently blinded validation trial it performed 4 times better than current clinical practice. It also holds great promise for wider application as a screen for the disease. Our potential In 2019 we will be embarking on a major project to analyse thousands of biobank samples, looking to build novel diagnostic screening tests. Biosignatures’ calculations suggest that existing biobanks are large enough to enable the company’s technologies to reliably generate 20 valuable diagnostic screens. For example - over 4,000 patients in the UKBiobank had no prostate cancer diagnosis when sampled but went onto to be diagnosed with the disease later. The market opportunity It is safe to say that if we can deliver on this vision - as we believe we can - it will be transformative for healthcare delivery world-wide. This is especially true for markets where genetic differences in populations mean that tests developed specifically for other populations may not work well. Developing tests for these markets plays perfectly to the company’s capabilities. A team with a track record Biosignatures’ management team has a strong background in technology companies including having founded, built and sold Nonlinear Dynamics Ltd.

TotalLab is an industry-led life science image analysis software company. We design technique specific software for better insight, handling and discovery of life science data, but we also specialise in creating bespoke software for life science and pharmaceutical industries. Everyday our software is being used by world-leading organisations and companies considered the founders of the biotech industry.